0000000000619491

AUTHOR

A. Jimeno

showing 2 related works from this author

Curing of an epoxy resin modified with nanoclay monitored by dielectric spectroscopy and rheological measurements

2006

Dielectric and rheological measurements have been performed in “real-time” to follow curing reaction on blends of a diglycidyl ether of bisphenol-A epoxy resin with 4,4-methylene bis(2,6-diethylaniline) hardener and different amounts of organically modified nanoclay (Nanofil 919) as modifier. The effect of the modifier and its amount on the curing reaction, as well as that of the curing temperature has been studied. Changes in molecular mobility in the reaction mixture have been investigated by dielectric relaxation spectroscopy. Evolutions of ionic conductivity and main relaxation have been analyzed and vitrification times have been obtained and compared with those obtained by rheological …

Materials scienceDiglycidyl etherNanocompositePolymers and PlasticsThermosetting polymerGeneral ChemistryEpoxyDielectricSurfaces Coatings and FilmsDielectric spectroscopychemistry.chemical_compoundchemistryvisual_artMaterials Chemistryvisual_art.visual_art_mediumOrganoclayComposite materialCuring (chemistry)Journal of Applied Polymer Science
researchProduct

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

2020

Abstract Background High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed …

Male0301 basic medicinePsychological interventionHuman immunodeficiency virus (HIV)MedizinContinuum of care; Europe; HIV infection; Key population; Sex; Anti-Retroviral Agents; Continuity of Patient Care; European Union; HIV; Humans; Male; HIV InfectionsHIV InfectionsContinuum of care; Europe; HIV infection; Key population; Sexmedicine.disease_causekey population0302 clinical medicineContinuum of careHIV Infection030212 general & internal medicineMen having sex with menContinuum of caremedia_commoneducation.field_of_study[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTransmission (medicine)Continuity of Patient CareEuropeInfectious DiseasesAcademicSubjects/MED00290Anti-Retroviral AgentsHIV infection continuum of care sex key population EuropeSexMicrobiology (medical)PopulationSocio-culturale03 medical and health sciencesAcquired immunodeficiency syndrome (AIDS)SDG 3 - Good Health and Well-beingmedicinemedia_common.cataloged_instanceHumansEuropean UnionEuropean unioneducationPandemicsHIV infection ; continuum of care ; sex ; key population ; Europebusiness.industrySARS-CoV-2COVID-19HIVmedicine.diseaseHIV infectioncontinuum of care030112 virologyMajor Articles and CommentariesKey populationAnti-Retroviral Agentbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct